With no generic versions and few comparable alternatives, Mylan’s Epipen has dominated the epinephrine injection device market for over a decade. However, this summer has marked the arrival of two new serious contenders, Sandoz and Teva.
The Israeli pharmaceutical market is set to rise from $ 1.75 billion in 2015 to around $ 2.12 billion by 2020, representing a compound annual growth rate of 3.9 %, according to research and consulting firm GlobalData.
The pharmaceutical market in Vietnam will expand in value from $3.5 billion in 2015 to an estimated $6.6 billion by 2020, registering a compound annual growth rate of 13.8%, according to research and consulting firm Global Data.
According to GlobalData analysts India’s pharmaceuticals market will skyrocket from $ 20 billion in 2015 to $ 55 billion by 2020. Generics will be primary growth driver, as India has become the largest provider of these types of medicines globally.
An ageing population, good health standards and a fully developed market make Japan truly a Land of the Rising Sun for pharma companies. By 2020, the market could edge US $ 80 billion, recent figures indicate. Yet, the country politics affect the market perspectives in the second largest pharmaceutical market.